Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2026-04-17 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a Korean ‘주요사항보고서(유상증자결정)’—a Significant Matters Report regarding the decision to conduct a paid‐in capital increase by issuing new shares (third‐party allotment). This is not a quarterly/annual earnings release or management discussion, nor merely an announcement of report publication. It directly concerns a share issue and capital change. Therefore it fits the 'Share Issue/Capital Change' category.
2026-04-17 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 88% confidence The document is titled '주요사항보고서(유상증자결정)' and details a decision on a paid-in capital increase by issuing new shares through a third‐party allocation, including share numbers, issuance price calculation, timelines, purposes, and regulatory compliance under the Capital Market Act. This is a formal announcement of a new share issue (capital change), matching the definition of SHA (Share Issue/Capital Change).
2026-04-15 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal notice of convening an extraordinary general meeting of shareholders (임시주주총회) including date, location, record date, board resolution date, and agenda items. This is part of the proxy materials sent to shareholders to provide meeting information and request votes. Therefore, it is a Proxy Solicitation & Information Statement.
2026-04-10 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is titled '감사보고서 제출' which translates to 'Audit Report Submission'. It contains detailed audit opinions, financial statement summaries for the current and prior fiscal years, and auditor information. The content includes audit opinions on consolidated and separate financial statements, financial data such as assets, liabilities, equity, revenues, and profits, and notes on accounting standards (K-IFRS). The document length is 3579 characters, which is relatively short but contains substantive audit and financial information rather than just an announcement or certification. There is no indication that this is a full Annual Report (10-K) or an Interim Report (IR). The focus is on the audit report itself, not on management discussion or earnings highlights. Therefore, the document fits the category of an Audit Report / Information (AR). FY 2025
2026-04-07 Korean
소속부변경
Regulatory Filings Classification · 95% confidence The document is a short announcement about a change in the company's listing or classification status within the exchange or regulatory body. It details a change in the company's category from 'investment caution' to 'venture company department' due to meeting certain certification requirements. This is not a financial report, audit, or management discussion, but rather a regulatory announcement about the company's status change. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-07 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is titled "감사보고서" (Audit Report) and contains the independent auditor’s opinion, audit basis, key audit matters, auditor’s and management’s responsibilities, and the audited financial statements (statement of financial position, income statement, cash flows, etc.). It does not serve as a full annual report but is a standalone audit report of financial statements for the fiscal years ended 2025 and 2024. Therefore, it matches the definition of Audit Report / Information. FY 2025
2026-04-07 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.